FOI 3952 – release of documents – opioid regulatory reform

The Pharmaceutical Benefits Advisory Committee (PBAC) ratified minutes and public summary documents


Ratified minutes of the PBAC’s consideration of the TGA’s consultation paper on prescription S8 opioid use and misuse in Australia (March 2018)

Public summary document of the PBAC’s consideration of the TGA prescription opioid regulatory reforms (December 2019)

Public summary of PBAC’s consideration of a request for nurse practitioners to be permitted to be secondary reviewers for opioids (December 2020)

Public summary of PBAC consideration of request to list a new pack size/maximum quantity of oxycodone 5 mg capsules for patients with severe disabling pain unresponsive to non-opioid analgesics

Ratified Consolidated Minutes Summary 11-2019 - TGA Opioid review on page16

PBAC submission March 2015 - BUPRENORPHINE

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
FOI release date:
Publication type:
General public

Minutes of PBAC meetings  which deal with the proposed opioid regulatory reforms.



Help us improve

If you would like a response please use the enquiries form instead.